GTHP · Guided Therapeutics Inc · Shareholders & Ownership
Substantial doubt about the company's ability to continue as a going concern.
“The factors below raise substantial doubt about the Company's ability to continue as a going concern. The financial statements do not include any adjustments that might be necessary from the outcome of this uncertainty.”View the 10-Q filed Aug 13, 2026
Every disclosed holder of GTHP in one list: 13F institutions, Schedule 13D and 13G filers, insiders (Forms 3, 4 and 5) and registered funds, each from its own latest filing. Holders nest by CIK and SEC reporting links, never by name, and each is summed once.
Who Owns GTHP
13F quarter Jun 30, 2021| Holder group | Shares | % Out |
|---|---|---|
| Institutional (13F) | 1 | 0.00% |
| Insiders (Forms 3, 4, 5) | 0 | 0.00% |
| 13D/G-only blocks | 5,804,865 | 6.01% |
| Remaining | 90,732,483 | 93.99% |
| Registered funds (N-PORT, not summed) | 0 | 0.00% |
Shares outstanding: 96,537,349, the issuer's latest cover-page count restated onto today's split basis.
13D/G-only counts each filer's latest 13D or 13G that no 13F report of the listing contains, that names no 13F filer and that no counted insider files. Funds are never summed: their shares sit inside their advisers' 13F reports.
Holders of GTHP
| # | Holder | Shares | As of | Notes |
|---|---|---|---|---|
| 1 |
Auctus Fund Management LLC
13G
CIK 1700205 · Unknown · Sep 30, 2024
Rule 13d-1(b), qualified institution
|
5,804,865 | ||
| 2 |
Steward Partners Investment Advisory, LLC
13F
CIK 1723397 · Registered investment adviser · Jun 30, 2021
|
1 |
Shares are restated onto today's split basis. Change compares each row with the same holder's previous filing in the same source; a dash means there is none to compare. Nested 13D/G, insider and fund rows are not summed, since a 13F report already holds them.